H. Lee Moffitt Cancer Center & Research Institute

Genetics

Researchers creating "designer lymph nodes"

Researchers at Moffitt Cancer Center are in the first phase of creating "designer lymph nodes." Designer lymph nodes are built with specialized gene-modified cells that are injected into patients and produce a pre-planned ...

Oncology & Cancer

Immune-targeting drug combo shows promise for lung cancer patients

Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a 5-year survival rate at only 18 percent, the development of new and improved treatment ...

Oncology & Cancer

Researchers develop CAR T cells that fight prostate cancer in bone

Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients. In a new article published today in Science ...

Oncology & Cancer

Mathematical model predicts patient outcomes to adaptive therapy

Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced ...

page 4 from 28